1
|
Orhan DE, Yildiz MM, Aybi EN, Dogan Topal B. Recent Advances in Electrochemical Affinity Biosensors: Detection of Biological Toxin Agents. Crit Rev Anal Chem 2025:1-20. [PMID: 40388323 DOI: 10.1080/10408347.2025.2501709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/21/2025]
Abstract
Biological toxins are metabolic products produced by living organisms. They exert deleterious effects on another organism through food, drinking water, inhalation, injection, ingestion, and absorption through the skin or mucous membranes. Health effects such as respiratory distress, muscle weakness, seizures, paralysis, and death depend on the amount and route of exposure to toxins. They act quickly and are fatal even in low doses, and can be considered bioterror agents due to their high potency, the reasonably long latency period before symptoms are exhibited, the difficulty in detecting or diagnosing their presence and identity, and their relative ease in production and stability in the environment. The development of selective and sensitive electrochemical biosensors has been of main importance for the quantification of biological toxins in low amounts in biological samples. This review examined the detection of various biological toxin agents using aptasensors and immunosensors from 2019 to 2025. This study provided information on the effect of the mechanism of biological toxins on another organism, modification of various electrochemical affinity biosensors, and smartphone-based and portable electrochemical biosensors used in the analysis of biological toxins.
Collapse
Affiliation(s)
- Doga Ekin Orhan
- Graduate School of Health Sciences, Ankara University, Ankara, Turkey
- Gulhane Faculty of Pharmacy, Department of Analytical Chemistry, University of Health Sciences, Ankara, Turkey
| | - Manolya Mujgan Yildiz
- Graduate School of Health Sciences, Ankara University, Ankara, Turkey
- Faculty of Pharmacy, Department of Analytical Chemistry, Lokman Hekim University, Ankara, Turkey
| | - Eda Nur Aybi
- Graduate School of Health Sciences, Ankara University, Ankara, Turkey
| | - Burcu Dogan Topal
- Faculty of Pharmacy, Department of Analytical Chemistry, Ankara University, Ankara, Turkey
| |
Collapse
|
2
|
Tchan BGO, Ngazoa-Kakou S, Aka N, Apia NKB, Hammoudi N, Drancourt M, Saad J. PPE Barcoding Identifies Biclonal Mycobacterium ulcerans Buruli Ulcer, Côte d'Ivoire. Microbiol Spectr 2023; 11:e0034223. [PMID: 37222600 PMCID: PMC10269924 DOI: 10.1128/spectrum.00342-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Accepted: 05/08/2023] [Indexed: 05/25/2023] Open
Abstract
Mycobacterium ulcerans, an environmental opportunistic pathogen, causes necrotic cutaneous and subcutaneous lesions, named Buruli ulcers, in tropical countries. PCR-derived tests used to detect M. ulcerans in environmental and clinical samples do not allow one-shot detection, identification, and typing of M. ulcerans among closely related Mycobacterium marinum complex mycobacteria. We established a 385-member M. marinum/M. ulcerans complex whole-genome sequence database by assembling and annotating 341 M. marinum/M. ulcerans complex genomes and added 44 M. marinum/M. ulcerans complex whole-genome sequences already deposited in the NCBI database. Pangenome, core genome, and single-nucleotide polymorphism (SNP) distance-based comparisons sorted the 385 strains into 10 M. ulcerans taxa and 13 M. marinum taxa, correlating with the geographic origin of strains. Aligning conserved genes identified one PPE (proline-proline-glutamate) gene sequence to be species and intraspecies specific, thereby genotyping the 23 M. marinum/M. ulcerans complex taxa. PCR sequencing of the PPE gene correctly genotyped nine M. marinum/M. ulcerans complex isolates among one M. marinum taxon and three M. ulcerans taxa in the African taxon (T2.4). Further, successful PPE gene PCR sequencing in 15/21 (71.4%) swabs collected from suspected Buruli ulcer lesions in Côte d'Ivoire exhibited positive M. ulcerans IS2404 real-time PCR and identified the M. ulcerans T2.4.1 genotype in eight swabs and M. ulcerans T2.4.1/T2.4.2 mixed genotypes in seven swabs. PPE gene sequencing could be used as a proxy for whole-genome sequencing for the one-shot detection, identification, and typing of clinical M. ulcerans strains, offering an unprecedented tool for identifying M. ulcerans mixed infections. IMPORTANCE We describe a new targeted sequencing approach that characterizes the PPE gene to disclose the simultaneous presence of different variants of a single pathogenic microorganism. This approach has direct implications on the understanding of pathogen diversity and natural history and potential therapeutic implications when dealing with obligate and opportunistic pathogens, such as Mycobacterium ulcerans presented here as a prototype.
Collapse
Affiliation(s)
- B. G. O. Tchan
- IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| | - S. Ngazoa-Kakou
- Plateforme de Biologie Moléculaire, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire
| | - N. Aka
- Unité des Mycobactéries Tuberculeuses et Atypiques, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire
| | - N. K. B. Apia
- Plateforme de Biologie Moléculaire, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire
| | - N. Hammoudi
- IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| | - M. Drancourt
- IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| | - J. Saad
- IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, Marseille, France
- IHU Méditerranée Infection, Marseille, France
| |
Collapse
|
3
|
KOMINE T, IHARA H, ONO K, YOSHIDA M, SUGIMOTO Y, INOHANA M, FUKANO H, KURATA O, WADA S. A case of mycobacteriosis associated with Mycobacterium pseudoshottsii in aquarium-reared fish in Japan. J Vet Med Sci 2022; 84:1617-1620. [PMID: 36273872 PMCID: PMC9791231 DOI: 10.1292/jvms.22-0318] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
In 2019, several aquarium-reared fish died at a sea life park in Japan. Necropsy revealed micronodules on the spleen in the dotted gizzard shad (Konosirus punctatus). Seven of 16 fish exhibited microscopic multifocal granulomas associated with acid-fast bacilli in the spleen, kidney, liver, alimentary tract, mesentery, gills, and/or heart. Bacterial cultures yielded isolates from the dotted gizzard shad and a Japanese sardine (Sardinops melanostictus). Microbiological and molecular biological examinations revealed the isolates as Mycobacterium pseudoshottsii. To our knowledge, this is the first isolation of M. pseudoshottsii from aquarium-reared fish.
Collapse
Affiliation(s)
- Takeshi KOMINE
- Laboratory of Aquatic Medicine, School of Veterinary
Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan,Correspondence to: Komine T: , Laboratory of Aquatic
Medicine, School of Veterinary Medicine, Nippon Veterinary and Life Science University,
1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan
| | - Hyogo IHARA
- Laboratory of Aquatic Medicine, School of Veterinary
Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - Kentaro ONO
- Laboratory of Aquatic Medicine, School of Veterinary
Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - Mitsumi YOSHIDA
- Laboratory of Aquatic Medicine, School of Veterinary
Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan
| | | | - Mari INOHANA
- Laboratory of Aquatic Medicine, School of Veterinary
Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - Hanako FUKANO
- Department of Mycobacteriology, Leprosy Research Center,
National Institute of Infectious Diseases, Tokyo, Japan
| | - Osamu KURATA
- Laboratory of Aquatic Medicine, School of Veterinary
Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - Shinpei WADA
- Laboratory of Aquatic Medicine, School of Veterinary
Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan
| |
Collapse
|
4
|
Ishwarlall TZ, Adeleke VT, Maharaj L, Okpeku M, Adeniyi AA, Adeleke MA. Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein. Front Immunol 2022; 13:1023558. [PMID: 36426350 PMCID: PMC9679648 DOI: 10.3389/fimmu.2022.1023558] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Accepted: 10/19/2022] [Indexed: 11/09/2023] Open
Abstract
Buruli ulcer is a neglected tropical disease that is characterized by non-fatal lesion development. The causative agent is Mycobacterium ulcerans (M. ulcerans). There are no known vectors or transmission methods, preventing the development of control methods. There are effective diagnostic techniques and treatment routines; however, several socioeconomic factors may limit patients' abilities to receive these treatments. The Bacillus Calmette-Guérin vaccine developed against tuberculosis has shown limited efficacy, and no conventionally designed vaccines have passed clinical trials. This study aimed to generate a multi-epitope vaccine against M. ulcerans from the major facilitator superfamily transporter protein using an immunoinformatics approach. Twelve M. ulcerans genome assemblies were analyzed, resulting in the identification of 11 CD8+ and 7 CD4+ T-cell epitopes and 2 B-cell epitopes. These conserved epitopes were computationally predicted to be antigenic, immunogenic, non-allergenic, and non-toxic. The CD4+ T-cell epitopes were capable of inducing interferon-gamma and interleukin-4. They successfully bound to their respective human leukocyte antigens alleles in in silico docking studies. The expected global population coverage of the T-cell epitopes and their restricted human leukocyte antigens alleles was 99.90%. The population coverage of endemic regions ranged from 99.99% (Papua New Guinea) to 21.81% (Liberia). Two vaccine constructs were generated using the Toll-like receptors 2 and 4 agonists, LprG and RpfE, respectively. Both constructs were antigenic, non-allergenic, non-toxic, thermostable, basic, and hydrophilic. The DNA sequences of the vaccine constructs underwent optimization and were successfully in-silico cloned with the pET-28a(+) plasmid. The vaccine constructs were successfully docked to their respective toll-like receptors. Molecular dynamics simulations were carried out to analyze the binding interactions within the complex. The generated binding energies indicate the stability of both complexes. The constructs generated in this study display severable favorable properties, with construct one displaying a greater range of favorable properties. However, further analysis and laboratory validation are required.
Collapse
Affiliation(s)
- Tamara Z. Ishwarlall
- Discipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa
| | - Victoria T. Adeleke
- Department of Chemical Engineering, Mangosuthu University of Technology, Durban, South Africa
| | - Leah Maharaj
- Discipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa
| | - Moses Okpeku
- Discipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa
| | - Adebayo A. Adeniyi
- Department of Chemistry, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa
- Department of Industrial Chemistry, Federal University Oye Ekiti, Oye-Ekiti, Ekiti State, Nigeria
| | - Matthew A. Adeleke
- Discipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa
| |
Collapse
|
5
|
Loukil A, Lalaoui R, Bogreau H, Regoui S, Drancourt M, Hammoudi N. Mycobacterium ulcerans Experimental Dormancy. Am J Trop Med Hyg 2022; 107:tpmd211327. [PMID: 35405654 PMCID: PMC9294675 DOI: 10.4269/ajtmh.21-1327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Accepted: 02/15/2022] [Indexed: 11/07/2022] Open
Abstract
Whether Mycobacterium ulcerans, the etiological agent of Buruli ulcer in numerous tropical countries, would exist in a dormant state as reported for closely related Mycobacterium species, has not been established. Six M. ulcerans strains were exposed to a progressive depletion in oxygen for 2 months, using the Wayne model of dormancy previously described for M. tuberculosis, and further examined by microscopy after staining of dynamic, dormant, and dead mycobacteria (DDD staining), microcalorimetry and subculture in the presence of dead and replicative M. ulcerans as controls. Mycobacterium ulcerans CU001 strain died during the progressive oxygen depletion and four of five remaining strains exhibited Nile red-stained intracellular lipid droplets and a 14- to 20-day regrowth when exposed to ambient air, consistent with dormancy. A fifth M. ulcerans 19423 strain stained negative in DDD staining and slowly regrew in 27 days. Three tested M. ulcerans strains yielded microcalorimetric pattern similar to that of the negative (dead) homologous controls, differing from that of the homologous positive (replicative) controls. The relevance of these experimental observations, suggesting a previously unreported dormancy state of M. ulcerans, warrants further investigations in the natural ecological niches where M. ulcerans thrive as well as in Buruli ulcer lesions.
Collapse
Affiliation(s)
- Ahmed Loukil
- Aix Marseille Univ., IRD, APHM, MEPHI, Marseille, France
| | - Rym Lalaoui
- Aix Marseille Univ., IRD, APHM, MEPHI, Marseille, France
- IHU-Méditerranée Infection, Marseille, France
| | - Hervé Bogreau
- IHU-Méditerranée Infection, Marseille, France
- Unité Parasitologie et Entomologie, Département Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées, IHU Méditerranée Infection, Marseille, France
- Aix Marseille Univ., IRD, SSA, AP-HM, VITROME, Marseille, France
| | | | - Michel Drancourt
- Aix Marseille Univ., IRD, APHM, MEPHI, Marseille, France
- IHU-Méditerranée Infection, Marseille, France
| | - Nassim Hammoudi
- Aix Marseille Univ., IRD, APHM, MEPHI, Marseille, France
- IHU-Méditerranée Infection, Marseille, France
| |
Collapse
|
6
|
Ishwarlall TZ, Okpeku M, Adeniyi AA, Adeleke MA. The search for a Buruli Ulcer vaccine and the effectiveness of the Bacillus Calmette-Guérin vaccine. Acta Trop 2022; 228:106323. [PMID: 35065013 DOI: 10.1016/j.actatropica.2022.106323] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2021] [Revised: 01/16/2022] [Accepted: 01/18/2022] [Indexed: 11/01/2022]
Abstract
Buruli Ulcer is a neglected tropical disease that is caused by Mycobacterium ulcerans. It is not fatal; however, it manifests a range of devastating symptoms on the hosts' bodies. Various drugs and treatments are available for the disease; however, they are often costly and have adverse effects. There is still much uncertainty regarding the mode of transmission, vectors, and reservoir. At present, there are no official vector control methods, prevention methods, or a vaccine licensed to prevent infection. The Bacillus Calmette-Guérin vaccine developed against tuberculosis has some effectiveness against M. ulcerans. However, it is unable to induce long-lasting protection. Various types of vaccines have been developed based specifically against M. ulcerans; however, to date, none has entered clinical trials or has been released for public use. Additional awareness and funding are needed for research in this field and the development of more treatments, diagnostic tools, and vaccines.
Collapse
|
7
|
Receveur JP, Bauer A, Pechal JL, Picq S, Dogbe M, Jordan HR, Rakestraw AW, Fast K, Sandel M, Chevillon C, Guégan JF, Wallace JR, Benbow ME. A need for null models in understanding disease transmission: the example of Mycobacterium ulcerans (Buruli ulcer disease). FEMS Microbiol Rev 2022; 46:fuab045. [PMID: 34468735 PMCID: PMC8767449 DOI: 10.1093/femsre/fuab045] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Accepted: 08/12/2021] [Indexed: 01/19/2023] Open
Abstract
Understanding the interactions of ecosystems, humans and pathogens is important for disease risk estimation. This is particularly true for neglected and newly emerging diseases where modes and efficiencies of transmission leading to epidemics are not well understood. Using a model for other emerging diseases, the neglected tropical skin disease Buruli ulcer (BU), we systematically review the literature on transmission of the etiologic agent, Mycobacterium ulcerans (MU), within a One Health/EcoHealth framework and against Hill's nine criteria and Koch's postulates for making strong inference in disease systems. Using this strong inference approach, we advocate a null hypothesis for MU transmission and other understudied disease systems. The null should be tested against alternative vector or host roles in pathogen transmission to better inform disease management. We propose a re-evaluation of what is necessary to identify and confirm hosts, reservoirs and vectors associated with environmental pathogen replication, dispersal and transmission; critically review alternative environmental sources of MU that may be important for transmission, including invertebrate and vertebrate species, plants and biofilms on aquatic substrates; and conclude with placing BU within the context of other neglected and emerging infectious diseases with intricate ecological relationships that lead to disease in humans, wildlife and domestic animals.
Collapse
Affiliation(s)
- Joseph P Receveur
- Department of Entomology, Michigan State University, East Lansing, MI 48824, USA
| | - Alexandra Bauer
- Department of Entomology, Michigan State University, East Lansing, MI 48824, USA
| | - Jennifer L Pechal
- Department of Entomology, Michigan State University, East Lansing, MI 48824, USA
| | - Sophie Picq
- Department of Entomology, Michigan State University, East Lansing, MI 48824, USA
| | - Magdalene Dogbe
- Department of Biological Sciences, Mississippi State University, Starkville, MS, USA
| | - Heather R Jordan
- Department of Biological Sciences, Mississippi State University, Starkville, MS, USA
| | - Alex W Rakestraw
- Department of Biological and Environmental Sciences, The University of West Alabama, Livingston, AL, USA
| | - Kayla Fast
- Department of Biological and Environmental Sciences, The University of West Alabama, Livingston, AL, USA
| | - Michael Sandel
- Department of Biological and Environmental Sciences, The University of West Alabama, Livingston, AL, USA
| | - Christine Chevillon
- Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Université de Montpellier (UM), Centre National de la Recherche Scientifique (CNRS), Institut pour la Recherche et le Développement, Montpellier, France
| | - Jean-François Guégan
- Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Université de Montpellier (UM), Centre National de la Recherche Scientifique (CNRS), Institut pour la Recherche et le Développement, Montpellier, France
- UMR Animal, santé, territoires, risques et écosystèmes, Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Centre de coopération internationale en recherche agronomique pour le développement (Cirad), Université de Montpellier (UM), Montpellier, France
| | - John R Wallace
- Department of Biology, Millersville University, Millersville, PA, USA
| | - M Eric Benbow
- Department of Entomology, Michigan State University, East Lansing, MI 48824, USA
- Ecology, Evolution and Behavior Program, Michigan State University, East Lansing, MI, USA
- AgBioResearch, Michigan State University, East Lansing, MI, USA
- Department of Osteopathic Medical Specialties, Michigan State University, East Lansing, MI, USA
| |
Collapse
|
8
|
Bahadoran P, Hammoudi N, Gaudart A, Saad J, Di Filippo Y, Drancourt M, Ruimy R. Case Report: A New Mycobacterium ulcerans Genotype Causing Buruli Ulcer in Côte d'Ivoire. Am J Trop Med Hyg 2021; 104:1782-1783. [PMID: 33819173 PMCID: PMC8103442 DOI: 10.4269/ajtmh.20-1307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2020] [Accepted: 01/18/2021] [Indexed: 11/07/2022] Open
Abstract
Mycobacterium ulcerans, the opportunistic pathogen causing Buruli ulcer, is reported to affect rural populations in 36 tropical countries. We report one case of Buruli ulcer in a peri-urban area in Côte d'Ivoire, confirmed by whole genome sequencing which indicated a M. ulcerans genotype previously unreported in Côte d'Ivoire.
Collapse
Affiliation(s)
- Philippe Bahadoran
- Department of Dermatology, Centre Hospitalier Universitaire de Nice, Université Côte D’Azur, Inserm, Nice, France
| | - Nassim Hammoudi
- IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, Marseille, France;,IHU Méditerranée Infection, Marseille, France
| | - Alice Gaudart
- Laboratoire de Bactériologie, Centre Hospitalier Universitaire de Nice, Hôpital de l’Archet II, Nice, France
| | - Jamal Saad
- IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, Marseille, France;,IHU Méditerranée Infection, Marseille, France
| | - Yoan Di Filippo
- Department of Dermatology, Centre Hospitalier Universitaire de Nice, Université Côte D’Azur, Inserm, Nice, France
| | - Michel Drancourt
- IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, Marseille, France;,IHU Méditerranée Infection, Marseille, France
| | - Raymond Ruimy
- Laboratoire de Bactériologie, Centre Hospitalier Universitaire de Nice, Hôpital de l’Archet II, Nice, France;,Université Côte D’Azur, Inserm, C3M, Nice, France;,Inserm U1065, C3M, Equipe 6, Nice, France,Address correspondence to Raymond Ruimy, Laboratoire de Bacteriologie, 151, Route de St Antoine de Ginestière, Nice 06000, France. E-mail:
| |
Collapse
|